1. Home
  2. Disease & Disorders
  3. New York, NY
  4. Eb Research Partnership

Eb Research Partnership

Eb Research Partnership is ranked #34 of 51 disease & disorders organizations in New York, NY, with an America's Best Score of 70 out of 100, based on its 2025 Form 990.

  • New York, NY
  • Tax-exempt since 2011
  • EIN: 27-2417202
ebresearch.org ProPublica Charity Navigator
Is this your organization? Claim it Tax filings by year Nominate
70OF 100 #34 of 51 in New York ranked disease & disorders organizations How this score is calculated

Organization summary

Eb Research Partnership is a 501(c)(3) organization, classified under Disease & Disorders (NTEE G80). Contributions are tax-deductible.

244 Madison Avenue 104, New York, NY 10016-2817

Among the 85 scored disease & disorders organizations in New York, Eb Research Partnership holds 32.4 months of operating reserves (peer median 11.2 months), runs a typical yearly deficit of 5.5% (peers: surplus of 0.8%), and has cut spending 2.2% a year (peers: grown spending 6.1% a year).

In fiscal year 2025 it reported $8,244,493 in revenue and $6,577,859 in expenses, with contributions making up 87.2% of revenue.

Work here? Claim this profile to add your mission, programs and logo.

What it does

From its own Form 990, as filed with the IRS

Mission · 2025 Form 990

Eb Research Partnership is the largest organizaion dedicated to funding research for treatments and a cure for epidermolysis bullosa, a group of devastating and life threatening genetic skin disorders that affect children from birth.

Main program · fiscal year 2025

  • Grants and money awarded for further research. Eb Research Partnership funds the most promising, innovative and potentially commercially viable treatments and potential cures for eb. Our research grants incorporate advances through the field of biomedicine for better treatments for all eb subtypes. Our scientific advisory board reviews all grant applications so that we are assured that grants are… Read more

    Grants and money awarded for further research. Eb Research Partnership funds the most promising, innovative and potentially commercially viable treatments and potential cures for eb. Our research grants incorporate advances through the field of biomedicine for better treatments for all eb subtypes. Our scientific advisory board reviews all grant applications so that we are assured that grants are relevant, innovative and could meaningfully improve the quality of life for those living with eb.

    $5,056,072 spent

Where each dollar went · fiscal year 2025

Of every dollar it spent, 77¢ went to programs, 9¢ to management and 14¢ to fundraising.

  • Programs $5,056,072
  • Management $571,278
  • Fundraising $950,509

In the organization's own words to the IRS, shown for context. None of this affects the America's Best Score, and a Form 990 describes programs without measuring their results.

America's Best Score

Free assessmentMethodology
Score70 / 100
Rank in New York#34 of 51
DesignationRanked

Score breakdown

MeasureThis organizationPoints
Operating reserves32.4 mo; 11.6 mo in cash22.5 / 25
Financial balance (median margin)−5.5%8 / 20
Transparency4 full 990s, latest TY202520 / 20
Program growth−2.2% / yr6.4 / 15
Track record15 years6 / 10
Debt load25.0% of assets7 / 10
Total69.9 → 70
Spending on programs
Not scored; America's Best needs 65%+
77%Meets

Compared with New York peers

MeasureThis organizationPeer median
Operating reserves32.4 mo11.2 mo
Typical margin−5.5%+0.8%
Spending growth−2.2% / yr+6.1% / yr
Debt load25.0%7.4%

Peers: the 85 New York disease & disorders organizations with a score, ranked or below the bar.

Tax filings by year

Financial data extracted from the Form 990 the organization filed with the IRS for each fiscal year. Revenue lines can exceed 100% when other items, such as fundraising event costs, are netted against total revenue.

Revenue$8,244,493Fiscal year 20252022: $6,450,44520222023: $7,430,62520232024: $5,518,23620242025: $8,244,4932025
Expenses$6,577,859Fiscal year 20252022: $7,021,82720222023: $7,652,30420232024: $7,194,53120242025: $6,577,8592025
Total assets$23,641,356Fiscal year 20252022: $22,585,70220222023: $24,668,01920232024: $22,929,76120242025: $23,641,3562025
Total liabilities$5,899,467Fiscal year 20252022: $4,598,56520222023: $6,902,56120232024: $6,840,59820242025: $5,899,4672025
Fiscal year ending December 2025
Revenue$8,244,493
Expenses$6,577,859
Net income$1,666,634
Net assets$17,741,889

Notable sources of revenue

Percent of total revenue
Contributions$7,189,016
Program services$0
Investment income$388,276
Other (net)$667,201

Assets / debt

Total assets$23,641,356
Total liabilities$5,899,467
Net assets$17,741,889

Compensation

Not in our extract for this year.

Fiscal year ending December 2024
Revenue$5,518,236
Expenses$7,194,531
Net income−$1,676,295
Net assets$16,089,163

Notable sources of revenue

Percent of total revenue
Contributions$5,491,713
Program services$0
Investment income$468,161
Other (net)−$441,638

Assets / debt

Total assets$22,929,761
Total liabilities$6,840,598
Net assets$16,089,163

Compensation

Not in our extract for this year.

Fiscal year ending December 2023
Revenue$7,430,625
Expenses$7,652,304
Net income−$221,679
Net assets$17,765,458

Notable sources of revenue

Percent of total revenue
Contributions$7,112,051
Program services$0
Investment income$552,333
Other (net)−$233,759

Assets / debt

Total assets$24,668,019
Total liabilities$6,902,561
Net assets$17,765,458

Compensation

Not in our extract for this year.

Fiscal year ending December 2022
Revenue$6,450,445
Expenses$7,021,827
Net income−$571,382
Net assets$17,987,137

Notable sources of revenue

Percent of total revenue
Contributions$6,106,138
Program services$0
Investment income$283,333
Other (net)$60,974

Assets / debt

Total assets$22,585,702
Total liabilities$4,598,565
Net assets$17,987,137

Compensation

Officers and key employees$351,481
Share of expenses5.0%

About this data

Figures come from IRS Form 990 filings, through the IRS Exempt Organizations Business Master File (2026-11-09) and e-filed returns. Form 990 data typically lags 12–24 months behind an organization's fiscal year. Found an error?